Group 1: Financial Performance - In 2024, the company achieved total revenue of 4.236 billion yuan, a year-on-year increase of 9.51% [2] - The net profit attributable to shareholders was 266 million yuan, a decrease of 23.24% year-on-year; the non-recurring net profit was 258 million yuan, down 25.22% [2] - In Q1 2025, the company reported revenue of 1.033 billion yuan, an 18.50% year-on-year growth; net profit attributable to shareholders was 78.53 million yuan, up 50.93% [2] Group 2: International Business - Over 70% of the company's products are sold internationally; in 2024, overseas revenue reached 3.252 billion yuan, a 10.41% increase, accounting for 76.78% of total revenue [2] Group 3: Core Product Performance - The pesticide segment generated 3.602 billion yuan in revenue in 2024, an 11.40% increase; fungicide revenue was 1.465 billion yuan, up 23.39%, while herbicide revenue reached 1.929 billion yuan, a 2.64% increase [3] - The production and sales volume of pesticides increased by 6.27% and 4.37% respectively, with a production-sales rate of 99.04% and capacity utilization of 94.01% [3] Group 4: Product Development and Market Strategy - The company is focusing on the development of key products such as: - Bacillus subtilis: Stable global demand with adjusted sales strategies [3] - Prothioconazole: Enhanced market presence through improved production efficiency and cost control [3] - 2,4-D: Maintained profitability despite market price fluctuations through strategic supplier partnerships [3] - The company is also expanding its portfolio with new products like: - Prothioconazole: Expected significant domestic market growth in 2025 [4] - Oxathiapiprolin: Aiming to increase market share with improved product recognition [4] Group 5: Future Plans and Risk Management - The company has not established clear merger and acquisition plans or identified potential targets, but will consider these based on strategic development and market conditions [5] - Emphasis on green development and environmental sustainability through energy-saving measures and technological advancements [4]
泰禾股份(301665) - 2025年5月19日投资者关系活动记录表